These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
930 related articles for article (PubMed ID: 17427618)
1. Outpatient management of anticoagulation therapy. du Breuil AL; Umland EM Am Fam Physician; 2007 Apr; 75(7):1031-42. PubMed ID: 17427618 [TBL] [Abstract][Full Text] [Related]
2. [Complications and risks associated with an anticoagulation therapy combining low molecular weight heparin and Warfarin after total replacement of large joints--our experience]. Míka P; Behounek J; Skoták M; Nevsímal L Acta Chir Orthop Traumatol Cech; 2004; 71(4):237-44. PubMed ID: 15456102 [TBL] [Abstract][Full Text] [Related]
3. Treatment of venous thromboembolism: adherence to guidelines and impact of physician knowledge, attitudes, and beliefs. Caprini JA; Tapson VF; Hyers TM; Waldo AL; Wittkowsky AK; Friedman R; Colgan KJ; Shillington AC; J Vasc Surg; 2005 Oct; 42(4):726-33. PubMed ID: 16242561 [TBL] [Abstract][Full Text] [Related]
4. Low-molecular-weight heparin as bridging anticoagulation during interruption of warfarin: assessment of a standardized periprocedural anticoagulation regimen. Douketis JD; Johnson JA; Turpie AG Arch Intern Med; 2004 Jun; 164(12):1319-26. PubMed ID: 15226166 [TBL] [Abstract][Full Text] [Related]
5. Early discharge of patients with venous thromboembolism: implications regarding therapy. Stein PD; Hull RD; Matta F; Yaekoub AY Clin Appl Thromb Hemost; 2010 Apr; 16(2):141-5. PubMed ID: 19833629 [TBL] [Abstract][Full Text] [Related]
6. The outpatient bleeding risk index: validation of a tool for predicting bleeding rates in patients treated for deep venous thrombosis and pulmonary embolism. Wells PS; Forgie MA; Simms M; Greene A; Touchie D; Lewis G; Anderson J; Rodger MA Arch Intern Med; 2003 Apr; 163(8):917-20. PubMed ID: 12719200 [TBL] [Abstract][Full Text] [Related]
7. Expedited discharge in trauma patients requiring anticoagulation for deep venous thrombosis prophylaxis: the LEAP Program. Bridges GG; Lee MD; Jenkins JK; Stephens MA; Croce MA; Fabian TC J Trauma; 2003 Feb; 54(2):232-5. PubMed ID: 12579045 [TBL] [Abstract][Full Text] [Related]
8. Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Geerts WH; Pineo GF; Heit JA; Bergqvist D; Lassen MR; Colwell CW; Ray JG Chest; 2004 Sep; 126(3 Suppl):338S-400S. PubMed ID: 15383478 [TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of a pharmacist-managed inpatient anticoagulation service for warfarin initiation and titration. Wong YM; Quek YN; Tay JC; Chadachan V; Lee HK J Clin Pharm Ther; 2011 Oct; 36(5):585-91. PubMed ID: 21070296 [TBL] [Abstract][Full Text] [Related]
11. Long-term, low-intensity warfarin therapy for the prevention of recurrent venous thromboembolism. Ridker PM; Goldhaber SZ; Danielson E; Rosenberg Y; Eby CS; Deitcher SR; Cushman M; Moll S; Kessler CM; Elliott CG; Paulson R; Wong T; Bauer KA; Schwartz BA; Miletich JP; Bounameaux H; Glynn RJ; N Engl J Med; 2003 Apr; 348(15):1425-34. PubMed ID: 12601075 [TBL] [Abstract][Full Text] [Related]
12. Treatment of pulmonary embolism: The use of low-molecular-weight heparin in the inpatient and outpatient settings. Hull RD Thromb Haemost; 2008 Mar; 99(3):502-10. PubMed ID: 18327398 [TBL] [Abstract][Full Text] [Related]
13. The pharmacology and management of the vitamin K antagonists: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Ansell J; Hirsh J; Poller L; Bussey H; Jacobson A; Hylek E Chest; 2004 Sep; 126(3 Suppl):204S-233S. PubMed ID: 15383473 [TBL] [Abstract][Full Text] [Related]
14. Treatment and prevention of venous thromboembolism. Hull RD; Pineo GF; Valentine KA Semin Thromb Hemost; 1998; 24 Suppl 1():21-31. PubMed ID: 9840689 [TBL] [Abstract][Full Text] [Related]
15. Antithrombotic therapy for venous thromboembolic disease: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Büller HR; Agnelli G; Hull RD; Hyers TM; Prins MH; Raskob GE Chest; 2004 Sep; 126(3 Suppl):401S-428S. PubMed ID: 15383479 [TBL] [Abstract][Full Text] [Related]
16. Risk of thromboembolism with short-term interruption of warfarin therapy. Garcia DA; Regan S; Henault LE; Upadhyay A; Baker J; Othman M; Hylek EM Arch Intern Med; 2008 Jan; 168(1):63-9. PubMed ID: 18195197 [TBL] [Abstract][Full Text] [Related]
17. Outpatient treatment of community acquired venous thromboembolism--the Christchurch experience. Heaton D; Han DY; Inder A N Z Med J; 2002 Jul; 115(1158):U105. PubMed ID: 12362180 [TBL] [Abstract][Full Text] [Related]
18. Single-arm study of bridging therapy with low-molecular-weight heparin for patients at risk of arterial embolism who require temporary interruption of warfarin. Kovacs MJ; Kearon C; Rodger M; Anderson DR; Turpie AG; Bates SM; Desjardins L; Douketis J; Kahn SR; Solymoss S; Wells PS Circulation; 2004 Sep; 110(12):1658-63. PubMed ID: 15364803 [TBL] [Abstract][Full Text] [Related]
19. [Treatment of venous thrombosis in cancer patients: practical aspects]. Laza-Achille M; Desruennes E; Di Palma M Bull Cancer; 2006 Mar; 93(3):271-81. PubMed ID: 16567314 [TBL] [Abstract][Full Text] [Related]
20. Low-molecular-weight heparin may alter point-of-care assay for international normalized ratio. Phillips EM; Buchan DA; Newman N; Rajan A; Zia S Pharmacotherapy; 2005 Oct; 25(10):1341-7. PubMed ID: 16185178 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]